In the last 10 years, many technologies have been
introduced to the market which not only support overall trial
management, but also help sponsors and CROs achieve more
complete data collection, reduce costs, boost compliance and
manage patients in real time. This includes the adoption of
electronic clinical outcome assessment technologies, which
are being increasingly utilised within trials of all sizes. Despite
a proven success record among the top pharmaceutical organisations, many sponsors and CROs still have reservations
about implementing eCOA strategies, often due to the
perceived costs. Colin Cleary, Program Director at CRF Health
concentrates on the development of an eCOA device supply
strategy.
https://www.jforcs.com/7/wp-content/uploads/2016/02/15-J106-2.pdf